Congenital Acardia

Congenital acardia means a baby is formed inside the womb without a working heart or with almost no heart at all. This rare problem almost always happens in a special kind of twin pregnancy where both babies share one placenta. In this setting, one baby grows normally (pump twin), and the other baby has no real heart and very poor body formation (acardiac twin). Doctors call this pattern twin reversed arterial perfusion, or TRAP sequence.[1]

Congenital acardia is a very rare and very severe birth problem in which a developing baby (fetus) has no working heart and often has missing or badly formed upper body parts. It usually happens in a special type of identical twin pregnancy called “twin reversed arterial perfusion (TRAP) sequence.” In TRAP, one twin (the “acardiac twin”) has no chance of living, and the other twin (the “pump twin”) must pump blood for both babies through shared blood vessels in the placenta. This extra work can damage the pump twin’s heart and can cause heart failure, too much fluid around the baby (polyhydramnios), and early birth. The main medical goal is always to protect the pump twin, not to cure the acardiac twin, because the acardiac twin is not viable and cannot survive outside the womb.

In congenital acardia, the acardiac baby cannot pump its own blood. Instead, the normal “pump” twin sends blood backward through shared blood vessels in the placenta. Because the blood flow goes in the wrong direction and has low oxygen when it reaches the acardiac twin, many body parts do not grow, such as the heart, head, chest, and upper limbs. Sadly, the acardiac twin cannot survive, and care focuses on protecting the pump twin.[2]

Congenital acardia is very rare. It happens in about 1 in 35,000 pregnancies and in around 1% of twin pregnancies where both twins share one placenta (monochorionic twins). In almost all cases, the twins are identical twins that started from one fertilized egg. Because the blood systems of the twins are joined inside the placenta, problems in the vessel connections can lead to acardiac twinning.[3]

Other names for congenital acardia

Doctors and researchers use several other names for congenital acardia. These names can sound different, but they usually describe the same basic problem. Knowing the common names can help when reading medical reports or research papers.[4]

  1. Acardiac twin – the malformed twin with no true heart or very poor heart development.[5]

  2. Acardia – short form that simply means “no heart.”

  3. Acardiac twinning – describes a twin pregnancy where one twin is acardiac.

  4. Twin reversed arterial perfusion sequence (TRAP sequence) – the most common medical name; it describes the reversed blood flow pattern from the pump twin to the acardiac twin.[6]

  5. Acardiac malformation – highlights that this is a serious birth defect.

  6. Acardius – another term for the acardiac fetus itself.

  7. Acardiac fetus in TRAP sequence – often used in ultrasound and radiology reports.[7]

Types of congenital acardia

Doctors divide congenital acardia into types based on which body parts are present or missing in the acardiac twin. These types are important because they show how severe the malformation is and how much tissue has developed. The acardiac twin is always non-viable, but the type can help doctors describe what they see on ultrasound.[8]

  1. Acardiac acephalus
    In this type, the acardiac twin has no head. The upper body, including the head, brain, and chest, is almost completely missing. Usually only the lower body, such as part of the abdomen and legs, is seen. This is the most common type. Because so much of the upper body is absent, the baby cannot develop normal organs.[9]

  2. Acardiac anceps
    In acardiac anceps, some parts of the head or face are present, but they are very abnormal. The brain and skull are poorly formed. The trunk and limbs may be more developed than in other types. Even though more body parts can be seen, the heart is still missing or not functional, so survival is not possible.[10]

  3. Acardiac acormus
    Here, only the head is present, and there is almost no trunk or limbs. The baby looks like a floating head without a full body. This is very rare. It shows how strongly blood flow problems can change early growth of the body in the womb.[11]

  4. Acardiac amorphous
    In this type, the acardiac twin has no clear body shape. It looks like an irregular mass of tissue with skin and maybe small bits of bone, but no clear head, trunk, or limbs. Because the shape is so unclear, it can be hard to tell that it is a malformed baby and not a tumor at first.[12]

Causes and risk factors of congenital acardia

The exact cause of congenital acardia is not fully known. Most experts think it starts from abnormal blood vessel connections in a monochorionic placenta early in pregnancy. These connections change blood flow and oxygen supply to the acardiac twin. Below are important causes and risk factors. Each one likely plays a part rather than acting alone.[13]

  1. Abnormal artery-to-artery placental connections
    In TRAP sequence, there are unusual direct artery-to-artery links between the twins’ umbilical arteries in the shared placenta. Blood from the pump twin flows backward into the acardiac twin, instead of each twin having its own separate flow. This reversed flow is the core cause that prevents the acardiac twin from forming a normal heart.[14]

  2. Reversed arterial perfusion
    Because blood enters the acardiac twin through the umbilical artery instead of the umbilical vein, it is low in oxygen when it reaches the developing tissues. Low-oxygen blood arrives first to the lower body, so the upper body and heart do not get enough oxygen to form. This reversed path leads to severe malformation.[15]

  3. Early disruption of heart development
    Heart development happens very early in the embryo. If blood flow is abnormal at this time, the forming heart tube may stop growing or break down. This early interruption can result in little or no heart tissue in the acardiac twin, which is the main feature of congenital acardia.[16]

  4. Shared monochorionic placenta
    Congenital acardia almost always happens in twins that share one placenta (monochorionic twins). This shared placenta makes abnormal vessel connections more likely. Separate placentas (dichorionic twins) almost never show this problem.[17]

  5. Monozygotic (identical) twinning
    Most acardiac cases are in identical twins, which come from one single fertilized egg that splits. The split and the way the placenta forms may affect how blood vessels join, which can set the stage for TRAP sequence and acardia.[18]

  6. Imbalance in blood pressure between twins
    If one twin has stronger blood pressure earlier, it may “push” blood into the other twin through shared vessels. Over time, this pump twin continues to drive blood into the acardiac twin, giving it just enough flow to grow as a mass, but not enough to form a normal heart or head.[19]

  7. Very early twin-to-twin transfusion–type changes
    TRAP sequence is sometimes described as a special form of twin-to-twin transfusion. The same general idea applies: unbalanced flows through placenta vessels. But in TRAP, the direction of flow and lack of heart tissue make it a much more severe pattern.[20]

  8. Problems in early placental angiogenesis (vessel growth)
    When the placenta forms, tiny vessels must grow in an ordered way. If this process is disturbed, abnormal connections may form between the twins. This faulty vessel growth in the shared placenta is thought to be a key background cause of acardiac twinning.[21]

  9. Unequal placental sharing
    Sometimes one twin has a larger share of the placenta than the other. Unequal sharing can worsen blood flow imbalances and may make it easier for one twin to become the pump twin and the other to become acardiac when abnormal vessel links exist.[22]

  10. Genetic or chromosomal abnormalities in the acardiac twin
    Some studies suggest the acardiac twin may have chromosomal or genetic problems. These may not cause TRAP by themselves, but they might make the affected twin more vulnerable to damage from low oxygen and abnormal blood flow.[23]

  11. Maternal age and twin pregnancy factors
    Higher maternal age and use of fertility treatments are linked with more twin pregnancies. More twin pregnancies may indirectly increase the chance of rare problems like TRAP sequence, but maternal age itself is not a direct proven cause of acardia.[24]

  12. Assisted reproductive technologies (ART)
    Some reports note TRAP sequence in pregnancies conceived with in-vitro fertilization or other ART. These methods are associated with more monozygotic twinning. Again, ART may raise the background risk of such twins, but does not directly “cause” acardia.[25]

  13. Early embryo damage from low oxygen (hypoxia)
    If an early embryo has long-lasting low oxygen levels because of abnormal flow, key organs like the heart and brain may not develop. This low oxygen situation, especially in the acardiac twin, is thought to be a strong contributing factor.[26]

  14. Impaired venous return from the acardiac twin
    In TRAP sequence, not only arteries but also veins between twins can be abnormal. Poor return of blood from the acardiac twin may worsen swelling and tissue damage and further reduce the chance of normal heart formation.[27]

  15. Placental thrombosis or vessel blockage
    Tiny clots or blockages in placental vessels may change pressure paths and encourage reversed flow patterns. These events are hard to see directly but are suggested in some pathological examinations of placentas from TRAP cases.[28]

  16. Inflammation or infection of the placenta (rare)
    In rare reports, inflammation in the placenta has been found, which might damage delicate vessels. While not a common cause, such changes might worsen an already unstable blood flow between twins.[29]

  17. Pre-existing maternal medical conditions
    Some mothers of TRAP pregnancies have conditions such as high blood pressure, diabetes, or autoimmune disease. These may affect placental health and vessel formation, but there is no clear proof that they directly cause acardiac twinning. They are probably background risk factors.[30]

  18. Smoking or toxin exposure in pregnancy (theoretical)
    Harmful substances may affect blood vessels in the placenta and embryo. However, clear direct links between smoking or toxins and congenital acardia are not firmly proven. Doctors still advise full avoidance of toxins in all pregnancies.[31]

  19. Previous monochorionic twin pregnancy with complications
    A history of complex monochorionic pregnancy could show that a mother tends to have placental patterns that favor abnormal vessel connections. Recurrence of TRAP is still very rare, but past problems may slightly raise background risk.[32]

  20. Random developmental error
    In many cases, no clear risk factor is found. The most honest explanation is that congenital acardia often results from random errors in early placental and vessel development in a shared placenta. It is not caused by anything the parents did or did not do.[33]

Symptoms and clinical features

Congenital acardia itself does not cause symptoms in the acardiac twin because that twin has no awareness and cannot survive. Instead, the important symptoms and signs relate to the mother and the healthy pump twin. These are things doctors notice during pregnancy or things the mother may feel.[34]

  1. Rapidly increasing tummy size
    The mother may feel that her abdomen is getting bigger faster than expected. This can be due to extra fluid around the babies (polyhydramnios) or the mass of the acardiac twin. Doctors may notice that the uterus measures larger than usual for the gestational age.[35]

  2. Breathlessness and discomfort
    Extra fluid or a very large uterus can press on the mother’s lungs and stomach. She may feel breathless, full, or uncomfortable, especially when lying flat. These symptoms are not specific, but they can suggest high amniotic fluid volume.[36]

  3. Preterm contractions
    Too much amniotic fluid or a large acardiac mass can stretch the uterus and trigger contractions early. This can lead to risk of preterm labor, which is one of the big dangers for the pump twin.[37]

  4. Decrease in fetal movements of the pump twin
    If the pump twin’s heart is under stress, its oxygen level can fall. The mother may notice less movement of the normal twin. This is an important sign that needs urgent checking.[38]

  5. Signs of heart strain in the pump twin on ultrasound
    On ultrasound, doctors can see a large heart, fast heart rate, or fluid around the heart and lungs of the pump twin. These signs show that the pump twin is working too hard to supply blood for both babies.[39]

  6. Hydrops fetalis in the pump twin
    Hydrops means severe swelling with fluid under the skin and in body cavities of the fetus. In TRAP sequence, this happens when the pump twin’s heart cannot keep up. Hydrops is a serious sign and greatly raises the risk of fetal death.[40]

  7. Polyhydramnios (too much amniotic fluid)
    Many TRAP pregnancies have excess amniotic fluid, especially around the pump twin. On ultrasound, this is seen as a very deep fluid pocket. Polyhydramnios can cause discomfort, breathlessness, and preterm labor in the mother.[41]

  8. Abnormal-looking second fetus on ultrasound
    The acardiac twin often looks like a misshaped mass at ultrasound, with absent or very abnormal head, chest, and heart. The limbs may be missing or malformed. There is no visible heartbeat. This imaging appearance is a key sign.[42]

  9. Reversed blood flow in the acardiac twin’s umbilical artery
    Color Doppler ultrasound shows blood moving from the placenta into the acardiac twin through the umbilical artery rather than the umbilical vein. This reversed flow is the hallmark of TRAP sequence and confirms the diagnosis.[43]

  10. Single umbilical artery in the acardiac twin
    Often the acardiac twin has only one artery in its umbilical cord. This is another imaging sign that the twin is malformed. It is not specific, but it supports the diagnosis when seen with other features.[44]

  11. No cardiac activity in the acardiac twin
    When doctors check with ultrasound, they cannot find any heart beating in the acardiac twin. Sometimes they also see no body movement. This helps to distinguish the acardiac twin from the healthy pump twin.[45]

  12. Differences in size between twins
    The acardiac twin may grow to be very large, sometimes even larger than the pump twin, because it keeps receiving blood. However, its tissue is not normal. The size ratio between the acardiac and pump twin is important for risk assessment.[46]

  13. Abnormal fetal shape on MRI or 3D ultrasound
    Advanced imaging can show more clearly that the acardiac twin has missing upper body parts and poorly formed internal organs. This confirms that the problem is not just a normal twin in an odd position.[47]

  14. Emotional distress for the parents
    Learning that one twin cannot survive while the other is at risk is very stressful. Parents may feel shock, sadness, fear, and guilt. Support from a specialist team and counselors is very important during this time.[48]

  15. Postnatal finding of an acardiac mass if undiagnosed prenatally
    In rare cases, the diagnosis is missed during pregnancy, and the acardiac twin is found at delivery as a malformed mass attached to the placenta. This situation is now less common because modern ultrasound usually finds TRAP sequence earlier.[49]

Diagnostic tests for congenital acardia

Physical examination tests

  1. General maternal physical examination
    The doctor checks the mother’s blood pressure, pulse, breathing, weight, and overall health. This exam helps detect signs of preeclampsia, anemia, or infection that could complicate the pregnancy. It also gives context for imaging findings and helps guide safe management of the pump twin.[50]

  2. Abdominal inspection and palpation
    The doctor looks at and gently feels the mother’s abdomen. They estimate the size and shape of the uterus and feel for contractions. If the uterus is very large for the gestational age, this may suggest excess amniotic fluid or a large acardiac mass, leading to further testing.[51]

  3. Fundal height measurement
    Using a simple tape measure from the pubic bone to the top of the uterus (fundus), the doctor checks if growth matches the weeks of pregnancy. In TRAP sequence, fundal height may be more than expected, prompting ultrasound to look for polyhydramnios or an unusual second fetus.[52]

  4. Assessment of signs of preterm labor
    The doctor checks for regular contractions, cervical changes, and pain. Because polyhydramnios and a large uterus can trigger early labor, this physical exam is important to decide if extra monitoring, medicines, or hospital admission are needed.[53]

Manual and bedside tests

  1. Handheld Doppler fetal heart rate check
    A small Doppler device is used on the mother’s abdomen to listen to the fetal heart rate. It mainly picks up the pump twin. A strong, regular heartbeat is a good sign, but if the heart is very fast or irregular, more detailed testing is needed.[54]

  2. Manual counting of fetal movements (kick count)
    The mother is asked to count how many times the baby moves over a set time each day. If movements drop, it may mean the pump twin is under stress. This is a simple home-based test that can prompt urgent review and imaging.[55]

  3. Manual blood pressure monitoring over time
    Frequent blood pressure checks help detect preeclampsia or other problems that could affect placental blood flow. Good control of maternal blood pressure supports better blood supply to the pump twin and overall pregnancy health.[56]

  4. Bedside assessment of amniotic fluid by quick ultrasound
    Even a brief bedside ultrasound can give a rough idea of fluid levels and fetal position. If fluid looks high or an unusual mass is seen, a detailed formal scan is arranged to look for TRAP sequence.[57]

Lab and pathological tests

  1. Routine maternal blood tests (CBC, blood group, etc.)
    Blood tests look for anemia, infection, and clotting problems. While they do not diagnose acardia directly, they help ensure that the mother is safe for possible procedures such as amnioreduction or fetal surgery to help the pump twin.[58]

  2. Screening for infections (TORCH, others) when indicated
    If the fetus has unusual findings, doctors may check for infections like toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH). These tests help rule out infectious causes of fetal malformations so that acardiac twinning is not confused with infection-related defects.[59]

  3. Genetic testing: karyotype and chromosomal microarray
    When TRAP sequence is diagnosed, doctors may offer genetic testing on fetal cells obtained through procedures like chorionic villus sampling or amniocentesis. These tests look for extra or missing chromosomes or smaller gene changes. They help understand if the pump twin has any hidden genetic problems.[60]

  4. Cell-free fetal DNA testing (non-invasive prenatal testing)
    A blood sample from the mother can be used to study small pieces of fetal DNA. This test mainly screens for common chromosomal problems in the pregnancy. It does not diagnose TRAP, but it adds genetic information that can support counseling about the pump twin.[61]

  5. Placental pathology after delivery
    After birth, the placenta and the acardiac twin can be examined under the microscope. Pathologists can confirm abnormal artery-to-artery and vein-to-vein connections and describe the extent of malformation. This gives final proof of congenital acardia and helps research.[62]

Electrodiagnostic and heart-monitoring tests

  1. Cardiotocography (CTG) for the pump twin
    CTG uses external sensors on the mother’s abdomen to record the pump twin’s heart rate over time and the mother’s contractions. Patterns of the heart rate can show if the baby is well or in distress. In TRAP sequence, CTG helps watch for heart failure or lack of oxygen in the pump twin.[63]

  2. Advanced fetal heart monitoring with Doppler waveforms
    Although Doppler is an ultrasound tool, doctors also treat it as a functional heart test. They study blood flow waveforms in the pump twin’s heart and major vessels. Abnormal waveforms can show rising pressure or failing heart function and guide timing of treatment.[64]

Imaging tests

  1. Standard obstetric ultrasound
    This is the main test for diagnosing congenital acardia. Ultrasound shows that there are monochorionic twins, one normal and one malformed. It reveals that the acardiac twin has no visible heart or clear upper body and that the pump twin looks normal. This test is safe and widely available.[65]

  2. Color Doppler ultrasound of umbilical vessels
    Color Doppler shows the direction and speed of blood flow. In TRAP sequence, it shows blood flowing from the pump twin through the placenta into the acardiac twin via the umbilical artery, which is the opposite of normal. This reversed flow pattern confirms the diagnosis.[66]

  3. Detailed fetal echocardiography of the pump twin
    Fetal echocardiography is a special ultrasound study of the fetal heart. It looks closely at the structure and function of the pump twin’s heart. Doctors check for enlargement, valve problems, and pumping strength. This helps predict the risk of heart failure and plan treatment.[67]

  4. Three-dimensional (3D) ultrasound
    3D ultrasound creates detailed images of the fetus in three dimensions. It can better show the strange shape of the acardiac twin and the absence of head or chest structures. This is useful for counseling parents and for surgical planning if an intervention is considered.[68]

  5. Fetal MRI (magnetic resonance imaging)
    Fetal MRI uses magnetic fields instead of X-rays. It can give clear pictures of soft tissues and help confirm which organs the acardiac twin has or lacks. MRI is usually used when ultrasound images are limited or when doctors need more detail about the anatomy before planning treatment.[69]

Non-pharmacological treatments (therapies and other care )

These are supportive measures used to watch and protect the mother and the pump twin. They do not cure the acardiac twin but help reduce risks.

  1. Regular high-quality ultrasound follow-up
    Repeated ultrasound scans help doctors measure the size of the acardiac fetus, check the pump twin’s heart function, and look for too much fluid around the baby. Careful monitoring allows early detection of heart failure or rapid growth of the acardiac mass so that timely action (like fetal surgery or earlier delivery) can be planned to protect the pump twin.

  2. Doppler blood-flow studies
    Doppler ultrasound is a special way to see how blood moves in the umbilical cords and fetal vessels. In TRAP sequence, reversed blood flow patterns confirm the diagnosis and help judge how hard the pump twin’s heart is working. Worsening Doppler findings can signal that the pump twin is in danger, guiding decisions about intervention and timing of delivery.

  3. Frequent maternal check-ups
    Regular clinic visits allow doctors to monitor the mother’s blood pressure, weight, symptoms like shortness of breath, and signs of preterm labor. Good antenatal care helps pick up complications early, such as pre-eclampsia or fluid overload, which can be more common in complicated twin pregnancies and can indirectly affect the pump twin’s well-being.

  4. Activity adjustment and rest
    Some women may be asked to reduce heavy physical work, avoid prolonged standing, and rest more if there are signs of preterm labor or maternal strain. While strict bed rest is not strongly proven by trials, gentle activity reduction can reduce discomfort and help the mother manage symptoms like breathlessness or pelvic pressure in high-risk twin pregnancies.

  5. Careful fluid and weight management
    Doctors may advise the mother to track weight gain, ankle swelling, and shortness of breath. In TRAP sequence, the pump twin can develop heart failure with fluid overload in the uterus, and the mother may feel very uncomfortable. Watching fluids and weight helps the team decide when additional treatment or earlier delivery may be needed.

  6. Psychological and emotional support
    Learning that one twin cannot survive while the other is at risk is extremely stressful. Counseling, psychological support, and support groups help parents cope with grief, anxiety, and difficult decisions. Emotional care improves adherence to follow-up and supports mental health both during pregnancy and after birth.

  7. Multidisciplinary fetal-medicine team care
    Management in a center with fetal-medicine specialists, maternal–fetal medicine doctors, neonatologists, and pediatric cardiologists gives the best chance for the pump twin. A team approach enables careful risk assessment, detailed planning for possible fetal procedures, and organized care around the time of delivery.

  8. Conservative (watchful) management in low-risk cases
    If the acardiac mass is small compared with the pump twin, and there is no heart failure or polyhydramnios, doctors may choose close observation without invasive intervention. This “wait and see” approach relies on frequent scans and can result in good outcomes when risk features are mild.

  9. Planning delivery in a tertiary hospital
    Delivery in a hospital with neonatal intensive care and pediatric cardiology allows rapid help for the pump twin at birth, including breathing support, heart ultrasound, and treatment of any heart failure. Planning also ensures that experienced doctors are available if emergency cesarean section becomes necessary.

  10. Education about warning signs
    Parents are taught to watch for sudden abdominal enlargement, strong contractions, vaginal fluid leakage, or reduced fetal movements. Early reporting of these signs allows quick evaluation and may prevent preterm birth or maternal complications, which are more common in complicated twin pregnancies.

  11. Individualized birth-timing strategy
    Doctors balance the risks of very early delivery against the dangers of waiting too long in a pregnancy where the pump twin is stressed. The goal is to reach the safest gestational age with the lowest chance of heart failure or stillbirth. This plan is updated after each ultrasound and clinical visit.

  12. Neonatal intensive care after birth
    After delivery, the pump twin may need oxygen, breathing machines, or medicines to support the heart and blood pressure. Skilled neonatal care can treat heart failure, infections, and breathing problems and improves survival and long-term outcomes for the surviving baby.

  13. Genetic and counseling review
    Although TRAP sequence is usually a placental vascular problem and not a classic inherited disease, genetic counseling can help parents understand recurrence risk, possible associated anomalies, and planning for future pregnancies. This reduces anxiety and supports informed choices.

  14. Documentation and birth planning written plan
    A detailed written care plan that summarizes diagnosis, risks, monitoring schedule, and possible interventions helps all health professionals work in the same direction. It also reassures the family that decisions are based on clear, shared information.

  15. Post-pregnancy follow-up for the mother
    After the pregnancy, the mother may need monitoring for anemia, blood-pressure problems, and emotional reactions such as grief and depression. Follow-up visits also allow discussion about future pregnancies, early ultrasound in the next pregnancy, and preconception health optimization.

(There are no evidence-based physical therapies like physiotherapy or exercise programs that change the course of congenital acardia itself; the key is specialized pregnancy and fetal care.)


Drug treatments

There is no specific drug that can make an acardiac fetus develop a normal heart. However, doctors sometimes use medicines to treat related conditions in the mother or the pump twin (for example, heart failure or high blood pressure). Below are examples of important drug classes, with information summarized from FDA prescribing information. These drugs are not used to “cure congenital acardia,” but to control complications.

  1. Furosemide (loop diuretic)
    Furosemide is a strong water tablet (diuretic) used to remove excess fluid in patients with edema and acute pulmonary edema related to heart failure or kidney and liver disease. [FDA labeling] explains that it is indicated to treat edema and can also be used for high blood pressure. Dosing is individualized and adjusted based on response and kidney function. Side effects include dehydration, low blood pressure, low potassium, and hearing problems at high doses. In pregnancy, use is cautious and specialist-guided.

  2. Digoxin (cardiac glycoside)
    Digoxin helps the heart pump more strongly and is indicated for mild to moderate heart failure and for controlling heart rate in chronic atrial fibrillation. [FDA prescribing information] notes that dose depends on age, weight, and kidney function, and levels must be monitored to avoid toxicity. Side effects can include nausea, confusion, and dangerous heart-rhythm changes. In TRAP pregnancies, if the pump twin develops certain rhythm problems or failure, fetal cardiology teams may sometimes consider digoxin, but evidence is limited and highly specialized.

  3. Labetalol (beta- and alpha-blocker)
    Labetalol is a blood-pressure–lowering medicine that blocks beta and alpha receptors. It is approved for treatment of hypertension and can be given orally or intravenously in severe cases. [FDA labels] describe starting with low doses and titrating up, with side effects such as low blood pressure, slow heart rate, and dizziness. Labetalol is widely used in pregnancy to treat high blood pressure, which may be more common in complicated twin pregnancies, but it does not treat acardia itself.

  4. Carvedilol (beta-blocker with alpha-blocking activity)
    Carvedilol is approved for heart failure, high blood pressure, and after some heart attacks. [FDA prescribing information] explains that it reduces the workload on the heart and can improve survival in heart-failure patients when added to standard therapy. Typical adult doses are slowly increased over weeks. Side effects include low blood pressure, slow heart rate, dizziness, and worsening asthma. Use in pregnancy and in fetuses must be specialist-directed; it is not a standard treatment for TRAP sequence itself.

  5. Enalapril (ACE inhibitor)
    Enalapril is an angiotensin-converting enzyme (ACE) inhibitor used to treat high blood pressure and symptomatic heart failure. The [FDA label] describes starting at low doses and adjusting according to blood pressure and kidney function. Side effects include low blood pressure, cough, high potassium, and kidney problems. Importantly, ACE inhibitors are usually avoided during pregnancy because of the risk of harm to the fetus, so they are not standard in TRAP pregnancies, but they may be used in the mother after pregnancy if heart problems persist.

  6. Spironolactone (mineralocorticoid receptor antagonist)
    Spironolactone blocks aldosterone and is used in combination therapy for certain types of heart failure and fluid retention. The [FDA labeling] shows that it reduces death and hospitalization when added to standard heart-failure therapy, but it carries a risk of high potassium, breast enlargement, and kidney problems. It is generally contraindicated in pregnancy and is not used to treat a fetus; instead, it is a tool for adult heart failure after pregnancy when needed.

  7. Metoprolol succinate (beta-1 selective blocker)
    Metoprolol succinate extended-release tablets are approved to treat high blood pressure, angina, and stable symptomatic heart failure. [FDA information] states that doses are titrated up to a maximum (often around 200 mg/day for heart failure) and must not be stopped suddenly to avoid worsening chest pain. Side effects include fatigue, slow pulse, low blood pressure, and mood changes. Use in pregnancy requires careful specialist judgment.

  8. Combination diuretic products (e.g., spironolactone plus thiazide)
    Combination tablets such as spironolactone with hydrochlorothiazide are approved for resistant fluid overload and high blood pressure in selected adults. The [FDA label] stresses that they should not be used unnecessarily and require careful monitoring of electrolytes and kidney function. Such medicines are relevant for long-term heart failure in adults, not for treating a fetus with acardia.

  9. Other antihypertensive combinations (e.g., enalapril with diuretics or calcium-channel blockers)
    Some fixed-dose combinations join enalapril with a diuretic or felodipine to improve blood pressure control. [FDA documents] describe their use in adult hypertension when single drugs are not enough. They are not typically used in pregnancy with TRAP sequence because of fetal safety concerns but illustrate the range of cardiovascular drugs that may be relevant for the mother after pregnancy if she has persistent hypertension.

  10. Supportive medicines (analgesics, tocolytics, steroids)
    Pregnant women with TRAP sequence may receive supportive medicines such as pain relievers during procedures, medicines to relax the uterus (tocolytics) to reduce contractions after fetal surgery, and steroids to mature the pump twin’s lungs if early delivery is likely. These medicines are chosen case-by-case from standard obstetric drug lists, not from specific “acardia drugs,” and are guided by obstetric and fetal-medicine standards.

(Because congenital acardia itself is not treatable by medicine, there are no 20 disease-specific “acardia drugs.” The drugs above are examples from FDA-approved therapies for heart failure and hypertension that may be part of overall care.)


Dietary molecular supplements

Supplements cannot fix an absent heart, but good maternal nutrition supports overall pregnancy health. Any supplement in pregnancy should only be used under medical care.

  1. Folic acid – Supports normal formation of the baby’s brain and spine and reduces the risk of neural tube defects. It is recommended for all women who may become pregnant.

  2. Iron – Prevents or treats anemia in the mother, improving oxygen delivery to the placenta. Adequate iron may help reduce fatigue and dizziness and supports better tolerance of any blood loss at delivery.

  3. Iodine – Supports healthy thyroid function in the mother and proper brain development in the fetus. Many prenatal vitamins contain iodine in safe doses.

  4. Calcium and vitamin D – Help maintain strong bones and normal muscle and heart function in the mother. They may reduce the risk of pregnancy-related high blood pressure in some populations.

  5. Omega-3 fatty acids (DHA/EPA) – Important for fetal brain and eye development. They may modestly lower the risk of very early preterm birth in some studies, though results vary.

  6. Vitamin B12 – Works with folate in red-blood-cell formation and nervous-system health. Deficiency can worsen anemia and neuropathy, so it is checked and replaced when low.

  7. Vitamin C – Supports immune function and helps the body absorb iron. It is usually obtained from a normal diet rich in fruits and vegetables; high-dose supplements are rarely needed.

  8. Magnesium – Important for nerve and muscle function. Low magnesium can worsen cramps; controlled magnesium therapy is used in some obstetric conditions (for example, pre-eclampsia) but must be doctor-directed.

  9. Zinc – Plays a role in cell growth and immune function. Mild deficiency is common in some populations and can be improved with balanced diet or prenatal supplements.

  10. Choline – Supports brain and liver function. Many prenatal formulations now include choline because it may help fetal brain development.

All these supplements are general pregnancy support, not specific treatment for congenital acardia.


Drugs for immunity boosting, regenerative and stem-cell approaches

For congenital acardia, there are no approved immunity-boosting drugs, regenerative drugs, or stem-cell products that can rebuild the fetus’s heart. Experimental stem-cell therapies in adults target damaged heart muscle after heart attacks or chronic heart failure, and even there the evidence is mixed and still under study. At present:

  • No stem-cell therapy can create a new, functioning heart in an acardiac fetus.

  • No immune-modulating medicine has been proven to prevent or reverse TRAP sequence.

  • Any mention of “immunity boosters” should be understood as general health support (healthy diet, vaccines when indicated, sleep) rather than a cure.

Because of this, it would be misleading to list six named “stem-cell drugs” as real treatments for congenital acardia. The honest, evidence-based answer is that research is ongoing, but nothing is established or approved for this condition.


Surgeries and fetal procedures

  1. Conservative management (no invasive procedure)
    In small, low-risk acardiac twins, doctors sometimes choose careful monitoring without surgery. The “procedure” here is watchful waiting with regular ultrasound and Doppler checks. It is chosen when the acardiac mass is small and the pump twin shows no heart strain, to avoid unnecessary risks of invasive surgery.

  2. Cord occlusion by radiofrequency ablation (RFA)
    RFA uses a needle placed into the umbilical cord of the acardiac twin under ultrasound guidance. High-frequency energy is applied to clot and seal the vessels, stopping blood flow to the acardiac mass while keeping the pump twin’s circulation intact. Studies show pump-twin survival rates above 80% in many series, though there are risks such as preterm rupture of membranes.

  3. Laser coagulation of placental or cord vessels
    In this procedure, a fetoscope is inserted into the uterus and a laser is used to seal the vessels supplying the acardiac fetus. The goal is the same as RFA: to disconnect the acardiac mass from the pump twin’s circulation. Some centers prefer laser techniques depending on anatomy and expertise.

  4. Bipolar cord coagulation or ligation
    Here, special bipolar forceps or clips are used to clamp and burn the acardiac twin’s cord, again under ultrasound guidance. It is another method of cord occlusion. Choice between RFA, laser, and bipolar coagulation depends on gestational age, placental position, and local experience, but all aim to reduce pump-twin heart strain.

  5. Planned early delivery of the pump twin
    If the pregnancy is advanced and the pump twin is near term, doctors may choose early delivery rather than fetal surgery. Induction of labor or cesarean section is performed with neonatal and cardiology teams ready. This avoids further strain on the pump twin’s heart and allows direct treatment after birth.


Prevention strategies

  1. Optimize maternal health (control diabetes, thyroid disease, and blood pressure before pregnancy).

  2. Attend early prenatal care so that twin pregnancies and placental problems can be detected early.

  3. Use careful ultrasound in early pregnancy to identify monochorionic twins and vascular complications.

  4. When using assisted reproductive technologies, discuss the goal of minimizing high-order multiples.

  5. Avoid smoking, alcohol, and non-prescribed drugs before and during pregnancy to reduce overall fetal risks.

  6. Maintain a healthy weight and balanced diet before conception.

  7. Ensure vaccinations are up to date (for example, rubella, influenza) as recommended.

  8. Seek referral to a fetal-medicine center early if an abnormal twin is suspected.

  9. Plan pregnancies with spacing that allows recovery between births.

  10. Consider early ultrasound in future pregnancies if there is a history of TRAP sequence.


When to see doctors

A pregnant person should see or contact a doctor urgently if any of the following occur:

  • Sudden, rapid increase in abdominal size or severe discomfort

  • Strong, regular contractions before term

  • Vaginal bleeding or gush of fluid

  • Marked decrease or change in the pump twin’s movements

  • New severe headache, visual changes, or very high blood pressure readings

  • New shortness of breath, chest pain, or swelling of face and hands

Even without symptoms, regular scheduled pregnancy visits and specialist fetal-medicine reviews are essential when TRAP sequence or congenital acardia is diagnosed, because careful monitoring and timely intervention can significantly improve pump-twin outcomes.


What to eat and what to avoid

  1. Eat: Plenty of fruits and vegetables for vitamins, minerals, and fiber.

  2. Eat: Whole grains (brown rice, whole-wheat bread, oats) for steady energy.

  3. Eat: Lean proteins (fish low in mercury, eggs, beans, lentils, lean meats) to support fetal growth.

  4. Eat: Dairy or calcium-fortified alternatives for calcium and vitamin D.

  5. Eat: Healthy fats (nuts, seeds, olive oil, avocado) in moderate amounts.

  6. Avoid: Alcohol, which can harm fetal brain development.

  7. Avoid: Smoking and second-hand smoke, which reduce oxygen to the fetus.

  8. Avoid: Recreational drugs and non-prescribed medicines.

  9. Avoid: High-mercury fish (like shark, swordfish, some large tuna) and undercooked meats or eggs.

  10. Avoid: Excessive caffeine and sugary soft drinks that may worsen heartburn and blood-sugar swings.


FAQs

  1. Is congenital acardia always fatal for the affected twin?
    Yes. Sadly, the acardiac twin cannot survive because it has no functioning heart and often lacks other vital organs. All treatment focuses on protecting the pump twin and the mother.

  2. Can medicines or vitamins grow a new heart in the acardiac twin?
    No. No medicine, vitamin, or stem-cell drug can make a heart develop when it never formed. Treatments aim to reduce the workload on the pump twin’s heart and to optimize maternal health.

  3. Why is the pump twin at risk?
    The pump twin must send blood through the placenta into the acardiac mass, which acts like a heavy load. This can cause heart enlargement, heart failure, too much amniotic fluid, and preterm birth if not managed.

  4. What is TRAP sequence?
    TRAP sequence (twin reversed arterial perfusion) is the medical name for this condition: one acardiac twin without a heart and one pump twin that supplies blood to both. Blood flow is reversed through the shared placenta.

  5. How is congenital acardia diagnosed?
    It is usually diagnosed by ultrasound when doctors see a severely malformed twin without a clear heartbeat, plus abnormal blood-flow patterns on Doppler showing reversed arterial perfusion from the pump twin.

  6. Is fetal surgery always needed?
    No. If the acardiac mass is small and the pump twin looks healthy, doctors may choose careful observation only. Fetal surgery is more often recommended when the acardiac mass is large or there are signs of pump-twin heart failure or polyhydramnios.

  7. What are the success rates of procedures like RFA or laser?
    Large series report pump-twin survival rates commonly around 75–90% after well-performed cord occlusion procedures, though outcomes vary by center, gestational age, and risk factors.

  8. Does congenital acardia happen because of something the parents did?
    In most cases, no. TRAP sequence is thought to be related to abnormal vascular connections in the placenta of monochorionic twins, not to lifestyle choices. Parents should not blame themselves.

  9. Will this problem happen again in the next pregnancy?
    Recurrence appears to be very rare, because it depends on having monochorionic twins and abnormal placental vessels. However, early ultrasound in future pregnancies is recommended to check the placenta and number of fetuses.

  10. Are there special risks for the mother?
    Yes. The mother may have more discomfort from a large uterus, risk of preterm labor, or high blood pressure. Good antenatal care reduces these risks, and emergency signs (severe headache, visual changes, bleeding, fluid loss) require urgent review.

  11. Can the acardiac twin feel pain?
    Because the acardiac twin lacks critical organs, including a functioning brain and heart in most cases, it does not experience life in the usual sense. Discussions about this are handled sensitively by the care team.

  12. What happens to the acardiac mass after cord occlusion?
    After blood flow is stopped, the acardiac mass usually stops growing and may shrink relative to the pump twin. It remains in the uterus until delivery and is delivered along with the placenta and pump twin.

  13. Can congenital acardia be seen on early scans?
    Yes. Modern high-resolution ultrasound can detect structural abnormalities and unusual blood flow in the first and early second trimester, especially in expert centers. Early detection allows better planning of monitoring or intervention.

  14. Do all centers offer fetal surgery for TRAP sequence?
    No. These procedures require specialized equipment and experienced teams, so they are usually available only in regional or national fetal-therapy centers. Referral to such a center is recommended when significant risk features are present.

  15. What is the most important thing parents can do after diagnosis?
    The most important steps are to attend all appointments, ask questions until they understand the plan, follow medical advice about rest and warning signs, and seek emotional support. Working closely with a specialized team gives the best chance for a healthy outcome for the pump twin and supports the family through a very difficult experience.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 05, 2025.

RxHarun
Logo